AbbVie Inc (ABBV)

Add to Watchlists
Create an Alert
Quickflows
107.63 -0.09  -0.08% NYSE Sep 28, 10:05 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ABBV News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
10/14/2021 Dividends 1.30 Normal dividend, declared September 10, 2021 and paid November 15, 2021
07/30/2021 Earnings Results Q2 2021 Earnings Results
07/30/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
07/14/2021 Dividends 1.30 Normal dividend, declared June 18, 2021 and paid August 16, 2021
05/07/2021 10:00 EST AGM 2020 Annual General Meeting
04/30/2021 Earnings Results Q1 2021 Earnings Results
04/30/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
04/14/2021 Dividends 1.30 Normal dividend, declared February 18, 2021 and paid May 14, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 53.73B
Total Expenses (TTM) 37.66B
Net Income (TTM) 6.663B

Balance Sheet View Statement

Total Assets (Quarterly) 147.97B
Total Liabilities (Quarterly) 135.38B
Shareholders Equity (Quarterly) 12.57B

Cash Flow Statement View Statement

Cash from Operations (TTM) 20.45B
Cash from Investing (TTM) -2.36B
Cash from Financing (TTM) -15.57B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
  • URL: https://www.abbvie.com
  • Investor Relations URL: https://investors.abbvie.com
  • HQ State/Province: Illinois
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Jul. 30, 2021
  • Next Ex-Dividend Date: Oct. 14, 2021
  • Last Ex-Dividend Date: Jul. 14, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 107.63
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
FBIOX Fidelity® Select Biotechnology 12.51%
HDV iShares Core High Dividend ETF 4.86%
XLV Health Care Select Sector SPDR® ETF 3.76%
VHT Vanguard Health Care ETF 3.43%
VHYAX Vanguard High Dividend Yield Index Adm 1.58%
VYM Vanguard High Dividend Yield ETF 1.58%
FISRX Franklin Income R 1.40%
CMLFX American Funds American Mutual 529F 1.28%
VIVAX Vanguard Value Index Inv 1.25%
VTV Vanguard Value ETF 1.25%
CIRFX American Funds Capital Income Bldr 529F 0.94%
IWF iShares Russell 1000 Growth ETF 0.85%

Comparables

Edit
RGNX Regenxbio Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co
MRK Merck & Co Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.